These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20667071)

  • 1. A comparison of methods of pathogen inactivation of FFP.
    Rock G
    Vox Sang; 2011 Feb; 100(2):169-78. PubMed ID: 20667071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Storage of thawed plasma for a liquid plasma bank: impact of temperature and methylene blue pathogen inactivation.
    Thiele T; Kellner S; Hron G; Wasner C; Nauck M; Zimmermann K; Wessel A; Warkentin TE; Greinacher A; Selleng K
    Transfusion; 2012 Mar; 52(3):529-36. PubMed ID: 21880044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on pathogen reduction technology for therapeutic plasma: an overview.
    Solheim BG; Seghatchian J
    Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen.
    Osselaer JC; Debry C; Goffaux M; Pineau J; Calomme G; Dubuc E; Chatelain B; Vandendaele MC; Hsu J; Rheinschmidt M; Lin L
    Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma.
    Smith J; Rock G
    Transfusion; 2010 Apr; 50(4):926-31. PubMed ID: 20051060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fresh-frozen plasma, pathogen-reduced single-donor plasma or bio-pharmaceutical plasma?
    Hellstern P
    Transfus Apher Sci; 2008 Aug; 39(1):69-74. PubMed ID: 18583192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogen reduction of blood components.
    Solheim BG
    Transfus Apher Sci; 2008 Aug; 39(1):75-82. PubMed ID: 18602343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of prion-filtered red cells suspended in pathogen-inactivated plasma (MB treated or solvent-detergent treated) for neonatal exchange transfusion.
    Hornsey VS; Casey C; McColl K; Young H; Drummond O; McMillan L; Morrison A; Prowse CV
    Vox Sang; 2011 Jul; 101(1):28-34. PubMed ID: 21175669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative and qualitative analysis of proteins in fresh frozen plasma obtained from whole blood donations and prepared with two photochemical treatments.
    Cid J; Ramiro L; Martínez N; Palomo M; Magallon O; Claparols M; Ortiz P; Puig L; Pla RP
    Transfus Apher Sci; 2008 Oct; 39(2):115-21. PubMed ID: 18710822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma transfusion in liver transplantation: a randomized, double-blind, multicenter clinical comparison of three virally secured plasmas.
    Bartelmaos T; Chabanel A; Léger J; Villalon L; Gillon MC; Rouget C; Gomola A; Denninger MH; Tardivel R; Naegelen C; Courtois F; Bardiaux L; Giraudeau B; Ozier Y
    Transfusion; 2013 Jun; 53(6):1335-45. PubMed ID: 22998014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers.
    Schlenke P; Hervig T; Isola H; Wiesel ML; Kientz D; Pinkoski L; Singh Y; Lin L; Corash L; Cazenave JP
    Transfusion; 2008 Apr; 48(4):697-705. PubMed ID: 18194378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updates on pathogen inactivation of plasma using Theraflex methylene blue system.
    Seghatchian J; Walker WH; Reichenberg S
    Transfus Apher Sci; 2008 Jun; 38(3):271-80. PubMed ID: 18487089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemovigilance data on the use of methylene blue virally inactivated fresh frozen plasma with the Theraflex MB-Plasma System in comparison to quarantine plasma: 11 years' experience.
    Politis C; Kavallierou L; Hantziara S; Parara M; Zervou E; Katsarou O; Hatzitaki M; Fountouli P; Gioka A; Tzioura K; Koumarianos S; Asariotou M; Richardson C
    Transfus Med; 2014 Oct; 24(5):316-20. PubMed ID: 25262924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Virus inactivated plasma].
    Köhler M; Wieding JU
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():73-6. PubMed ID: 8000259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light.
    Yarranton H; Lawrie AS; Mackie IJ; Pinkoski L; Corash L; Machin SJ
    Transfusion; 2005 Sep; 45(9):1453-8. PubMed ID: 16131377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of plasma proteins in whole blood-derived fresh frozen plasma prepared with three pathogen reduction technologies.
    Larrea L; Ortiz-de-Salazar MI; Martínez P; Roig R
    Transfus Apher Sci; 2015 Jun; 52(3):305-10. PubMed ID: 25656475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative evaluation of plasma after methylene blue and white light treatment in four Chinese blood centers.
    Chunhui Y; Guohui B; Hong Y; Xiaopu X; Zherong B; Mingyuan W; Xinsheng Z; Juanjuan W; Changqing L; Wuping L
    Transfus Apher Sci; 2013 Dec; 49(3):631-9. PubMed ID: 23928128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of proteins in riboflavin and UV light-treated FFP during 1 year of storage at -18°C.
    Ettinger A; Miklauz MM; Hendrix BK; Bihm DJ; Maldonado-Codina G; Goodrich RP
    Transfus Apher Sci; 2012 Feb; 46(1):15-8. PubMed ID: 22115607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
    Janetzko K; Lin L; Eichler H; Mayaudon V; Flament J; Klüter H
    Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogen-reduction systems for blood components: the current position and future trends.
    Seghatchian J; de Sousa G
    Transfus Apher Sci; 2006 Dec; 35(3):189-96. PubMed ID: 17110168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.